• Prof. Ravid Straussman

    The study of resistance to anti-cancer therapy

    We use cutting-edge, high-throughput technologies to study the different mechanisms that render cancer cells resistant to anti-cancer therapy. Our goal is to advance anti-cancer precision medicine for the creation of better treatment options for cancer patients. Topics of interest include:

    • Tumor microenvironment-mediated chemoresistance
    • The human microbiome and chemoresistance
    • Cell autonomous rewiring as a mechanism for chemoresistance
    • The study of drug tolerant persisters
    • Study of the timing and mechanisms that drive genetic chemoresistance
    • Common models: Melanoma, Breast cancer, lung cancer, pancreatic cancer
    website of Prof. Ravid Straussman ravidst@weizmann.ac.il